Jordan Grafman

Title: Jordan Grafman: Innovator in Tauopathy Diagnosis

Introduction

Jordan Grafman is a notable inventor based in Riverwoods, IL (US). He has made significant contributions to the field of medical diagnostics, particularly in the assessment of tauopathies. His innovative approach has the potential to enhance the understanding and diagnosis of neurodegenerative diseases.

Latest Patents

Jordan Grafman holds a patent for a method titled "Biomarkers in nasal exhaled breath." This method involves diagnosing or assessing the risk of tauopathy in individuals. The process includes collecting a nasal sample of exhaled breath, analyzing it for the presence of tau protein, and determining the concentration of tau protein in the sample. The concentration level indicates susceptibility to tauopathy, providing a non-invasive diagnostic tool.

Career Highlights

Throughout his career, Jordan has worked with esteemed institutions such as Northwestern University and the Rehabilitation Institute of Chicago. His work has focused on advancing the understanding of neurological conditions and improving diagnostic methods.

Collaborations

Jordan Grafman has collaborated with notable colleagues, including Christina M. Zelano and Katherina K. Hauner. Their combined expertise has contributed to the development of innovative diagnostic techniques.

Conclusion

Jordan Grafman's work exemplifies the intersection of innovation and medical science, particularly in the realm of tauopathy diagnosis. His contributions are paving the way for improved diagnostic methods that could significantly impact patient care.